辛辛那提大学团队开发结合深度学习与统计方法的乳腺癌生存预测模型
AI breast cancer survival model could improve accuracy and personalize care
辛辛那提癌症中心研究团队在《Journal of Statistical Theory and Practice》发表新型乳腺癌生存预测模型,融合深度学习框架与统计方法以提升预测精度。该研究利用包含 1,980 名患者的公开数据集进行测试,结果显示其生存结局预测准确性优于对照模型。团队计划使用更大规模且更多样化的患者数据集对模型进行进一步评估。
New University of Cincinnati Cancer Center research published in the Journal of Statistical Theory and Practice describes the potential for a more robust and accurate breast cancer survival model that combines statistical methods with a deep learning framework. The goal is to give physicians a better tool to make personalized care decisions for each patient.
How does the new survival model differ from current approaches?
Each case of breast cancer is unique and depends upon many variables, including clinical, biological and genetic factors. Traditional survival models are useful to estimate each patient's risk and expected outcomes, but they cannot fully account for how the complex relationships between these factors affect survival prediction for a given patient.
"We wanted to explore whether combining statistical methods with deep learning could capture these relationships and improve the overall survival prediction," said corresponding author Wedad Alatebi, a doctoral student in the Department of Biostatistics, Health Information and Data Science in UC's College of Medicine. "Deep learning can be described as teaching a computer to recognize complex patterns in patient data."
Co-author Anand Seth, Ph.D., said the "fusion" strategy combining multiple statistical approaches allows a much more precise prediction outcome. The deep learning framework allows patients who are seemingly similar to be stratified into more specific risk groups.
"That way, you can individualize therapy for a specific group of patients," said Seth, research manager in the Department of Biostatistics, Health Information and Data Science in UC's College of Medicine.
How does the model account for genetic information?
Tumor genetic information can improve survival models, but genetic testing is not always feasible or cost-effective in hospitals worldwide. To account for this, Alatebi and her team created simulated gene expression data that are built into the new model.
"We first transform the clinical information into a better representation of patients' risk," she said. "We then simulate biologically plausible molecular features to explore how integrating molecular and clinical information may improve survival prediction. The model also considers similarities between patients and includes uncertainty in its predictions."
How did the new model perform on a real-world data set?
The team tested the new model on a publicly available data set of 1,980 breast cancer patients' clinical and survival data. In this data set, the model achieved higher accuracy at predicting survival outcomes than the comparison models in the study.
"It was exciting to see how much information we could gain by combining different approaches rather than relying on one method alone," Alatebi said.
While more research is needed to determine the model's precise accuracy, Seth said even being a few percentage points more accurate could provide physicians with more confidence in the treatment strategies and prognoses for their patients.
"This is a personalized medicine approach," added co-author Shesh Rai, Ph.D., director of the Cancer Center's Biostatistics and Informatics Shared Resource and professor in the Department of Biostatistics, Health Information and Data Science in UC's College of Medicine. "We're either using or simulating the patients' gene signatures in addition to other features, other demographics, combining all of this together, and from there predicting what could actually happen."
What are the next steps for the research?
Alatebi and the team will further evaluate the model using larger and more diverse patient data sets. Their long-term goal is to develop a tool that could help physicians to better identify patient risk and support more personalized treatment and follow-up decisions.
"These deep learning–based models are not meant to replace physicians," she said. "They are tools that could help physicians understand complex patient information and support their decisions. This combination of statistics, machine learning and cancer research has been exciting for me to help us improve how we understand patient outcomes."
More information
W. Alatebi et al., A Hybrid Statistical Deep Learning Framework for Breast Cancer Survival Prediction Using Covariate Transformation and Simulated Gene Expression Data, Journal of Statistical Theory and Practice (2026). DOI: 10.1007/s42519-026-00641-9
Key medical concepts
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: AI breast cancer survival model could improve accuracy and personalize care (2026, October 23) retrieved 23 October 2026 from https://medicalxpress.com/news/2026-10-ai-breast-cancer-survival-accuracy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com